Stricter FDA COVID-19 vaccine policy could limit future access; $3.2M Medicare fraud scheme involving fake medical equipment; lower-income countries hit $250M milestone in self-funded vaccine efforts – Morning Medical Update

FDA tightens COVID vaccine policy for low-risk groups, raising access concerns

The Food and Drug Administration (FDA) is shifting its COVID-19 vaccine strategy to prioritize older adults and high-risk individuals, while requiring new large-scale studies before extending future booster approvals to healthy children and younger adults. In a New England Journal of Medicine article, FDA leaders said the move will ensure "gold-standard science" supports vaccine use among low-risk groups. But critics worry the stricter approach could limit access and fuel skepticism, especially if insurers stop covering shots for broader populations. Health experts warn the policy overlooks risks like long COVID and public demand to protect vulnerable loved ones. Read more from npr.

$3.2 million Medicare fraud scheme involving fake medical equipment

Julian Lopez, a Cuban national living in Miami-Dade County, was sentenced to 30 months in prison and ordered to pay nearly $1.5 million in restitution for his role in a $3.2 million Medicare fraud scheme. Prosecutors say Lopez collected and sold beneficiary IDs to a sham durable medical equipment company, which then billed Medicare for orthotic braces that were never delivered. Lopez pleaded guilty to two counts of health care fraud in February.

Lower-income countries hit $250 million milestone in self-funded vaccine efforts

In a record show of financial commitment, lower-income nations supported by Gavi, the Vaccine Alliance, contributed nearly $255 million to their own immunization programs in 2024 — a 19% increase from 2023. The majority (84%) of the funding came from domestic sources, signaling growing national ownership of vaccine delivery. All countries met their 2024 co-financing obligations, even those facing major challenges like Chad, Haiti and Mali. Gavi projects co-financing to rise further to $300 million in 2025, with low- and middle-income countries expected to contribute $4 billion to vaccination programs between 2026 and 2030. The announcement came during a World Health Assembly event celebrating sustainable immunization financing.